Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 721 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
2. Cita con resumen
Anónimo. Guanfacine et déficit de l'attention avec hyperactivité. Prescrire 2017;37:329-32. [Ref.ID 101647]
3. Cita con resumen
Anónimo. Pitolisant et narcolepsie. Prescrire 2017;37:333-5. [Ref.ID 101643]
6. Cita con resumen
Chanq Z, Quinn PD, Hur K, Gibbons RD, Sjolander A, Larsson H, D'Onofrio BM. Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 2017;74:597-603. [Ref.ID 101569]
7. Cita con resumen
Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoen-baum M, Hutchins D, Brennan T, Loewen-stein G. Association between academic medical center pharmaceutical detailing policies and physician prescribing. JAMA 2017;317:1785-95. [Ref.ID 101559]
8. Cita con resumen
Anónimo. Benfluorex: un bilan 1976-2015. Prescrire 2016;36:755. [Ref.ID 100895]
9. Cita con resumen
Anónimo. FDA places hold on experimental ADHD drug. DIA Daily 2016:3. [Ref.ID 100765]
10. Cita con resumen
Anónimo. FDA approves appetite suppressant. DIA Daily 2016:2. [Ref.ID 100763]
11. Cita con resumen
Casassus B. Drug scandals in France: have the lessons been learnt?. Lancet 2016;388:550-2. [Ref.ID 100574]
12.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
13. Cita con resumen
Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 2016;315:2424-34. [Ref.ID 100458]
14.Enlace a cita original Cita con resumen
Hoshen MB, Benis A, Keyes KM, Zoëga H. Stimulant use for ADHD and relative age in class among children in Israel. Pharmacoepidemiol Drug Saf 2016;25:652-60. [Ref.ID 100395]
15. Cita con resumen
Jackson JW. The cardiovascular safety of methylphenidate. BMJ 2016;353:i2874. [Ref.ID 100356]
17. Cita con resumen
18.Enlace a cita original Cita con resumen
Anónimo. Síndrome serotoninérgico: un efecto adverso que se puede prevenir . Butlletí de Farmacovigilància de Catalunya 2016;14:1-2. [Ref.ID 100185]
20.Tiene citas relacionadas Cita con resumen
Anónimo. In brief: oral phenylephrine for nasal congestion. The Medical Letter on Drug and Therapeutics Bulletin 2015;57:174. [Ref.ID 99738]
Seleccionar todas
 
 1 a 20 de 721 siguiente >>